Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Otsuka Corporation    4768   JP3188200004

OTSUKA CORPORATION

(4768)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Tokyo Stock Exchange
01/21/2021 01/22/2021 01/25/2021 01/26/2021 01/27/2021 Date
5100 5170 5300 5400 5520 Last
383600 396100 515300 454700 721300 Volume
+2.10% +1.37% +2.51% +1.89% +2.22% Change
Financials
Sales 2020 830 B 7 970 M 7 970 M
Net income 2020 40 294 M 387 M 387 M
Net cash position 2020 183 B 1 761 M 1 761 M
P/E ratio 2020 25,9x
Yield 2020 2,11%
Sales 2021 868 B 8 339 M 8 339 M
Net income 2021 44 630 M 429 M 429 M
Net cash position 2021 203 B 1 947 M 1 947 M
P/E ratio 2021 23,5x
Yield 2021 2,24%
Capitalization 1 047 B 10 057 M 10 053 M
EV / Sales 2020 1,04x
EV / Sales 2021 0,97x
Nbr of Employees 8 912
Free-Float 57,5%
More Financials
Company
Otsuka Corporation specializes in IT services for businesses and public institutions. Net sales break down by activity as follows: - development and integration of software and systems (61%): integrated management software packages, planning and design software, business process management solutions, information platforms, document management software, voice and data transmission solutions, etc. The group also... 
More about the company
Notations Surperformance© of Otsuka Corporation
Trading Rating : Investor Rating :
More Ratings
All news about OTSUKA CORPORATION
01/12PRESS RELEASE : Helsinn Announces First Patient Dosed in Phase 1/2 Study of TAS0..
DJ
2020OTSUKA CORPORATION : Ex-dividend day for final dividend
FA
2020Dual-Listed Aurinia In Collaboration and Licensing Agreement with Otsuka Phar..
MT
2020Aurinia Pharmaceuticals to Collaborate With Otsuka Pharmaceutical for Develop..
MT
2020OTSUKA : Reports Results of Two Global Clinical Trials for Uncontrolled Hyperten..
MT
2020OTSUKA CORPORATION : quaterly earnings release
2020Japan looks to AI as coronavirus challenges go-and-see quality control mantra
RE
2020OTSUKA CORPORATION : half-yearly earnings release
2020Mylan gets Indian regulatory approval for tuberculosis drug
RE
2020Johnson & Johnson cuts price of TB drug bedaquiline in poorer countries
RE
2020OTSUKA CORPORATION : annual earnings release
2019OTSUKA CORPORATION : Ex-dividend day for final dividend
FA
2019FDA approves Intra-Cellullar's schizophrenia drug, shares soar 85%
RE
2019Musashi Seimitsu to co-develop new engine with Israel's Aquarius
RE
2019OTSUKA CORPORATION : Half-year results
CO
More news
News in other languages on OTSUKA CORPORATION
2020BOURSES ASIATIQUES : Tokyo rassurée, Hong Kong préoccupée
2020Tokyo clôture en hausse, le moral des entreprises japonaises s'améliore
2020OTSUKA CORPORATION : publication des résultats trimestriels
2020OTSUKA CORPORATION : Veröffentlichung des Quartalsergebnisses
2020Tokyo finit en retrait, plombée par SoftBank Group
More news
Analyst Recommendations on OTSUKA CORPORATION
More recommendations
Chart OTSUKA CORPORATION
Duration : Period :
Otsuka Corporation Technical Analysis Chart | 4768 | JP3188200004 | MarketScreener
Technical analysis trends OTSUKA CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 5 580,83 JPY
Last Close Price 5 520,00 JPY
Spread / Highest target 8,70%
Spread / Average Target 1,10%
Spread / Lowest Target -13,9%
EPS Revisions
Managers and Directors
NameTitle
Yuji Otsuka President, Representative Director & GM-Marketing
Minoru Sakurai Director & General Manager-Technology
Kazuyuki Katakura Director, GM-Sales & Deputy GM-Marketing
Toshiyasu Takahashi Director & Senior Lead Managing Executive Officer
Katsuhiro Yano Director & Managing Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
OTSUKA CORPORATION-2.75%9 876
VERISK ANALYTICS-9.20%30 648
SAMSUNG SDS CO.,LTD.16.25%14 198
CHANGE HEALTHCARE INC.28.74%7 338
REPLY S.P.A.8.81%4 718
CHINA TRANSINFO TECHNOLOGY CO., LTD-3.29%4 529